Physician

Martha Hosford Skapof, M.D.

According to 2025 Medicare claims, Martha Skapof, M.D. (NPI: 1457301657) practices hematology/oncology in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Cecil, MD. This provider's primary affiliated billing organization is CHRISTIANA CARE HEALTH SERVICES INC (NPI: 1306375373; TIN: 510103684) and primary practice location at 21921-5549. Skapof is affiliated with the eBrightHealth ACO (ACO ID: A3053), participating under the MSSP model.

Skapof's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 516 traditional Medicare patients, billed 102,664 HCPCS/CPT codes, and received $1,640,428 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,623 prescription claims across 277 beneficiaries totaling $3,203,925 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 113 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,230,816 to $3,203,925. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $6,595 to $1,638.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	783	98,220	$1,291,146
2016	780	143,268	$1,811,473
2017	755	185,021	$1,639,784
2018	669	124,096	$1,549,857
2019	652	127,970	$1,692,485
2020	580	132,374	$1,805,997
2021	610	148,592	$1,944,673
2022	527	98,581	$1,242,551
2023	480	105,716	$1,362,759
2024	516	102,664	$1,640,428

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	246	1,393	$1,230,816
2016	263	1,541	$1,067,448
2017	276	1,569	$1,286,907
2018	242	1,404	$1,877,022
2019	254	1,318	$1,987,916
2020	276	1,326	$1,911,048
2021	275	1,415	$2,577,193
2022	272	1,448	$3,081,858
2023	248	1,464	$3,151,606
2024	277	1,623	$3,203,925

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	207	$33,501
2016	N/R	165	$21,098
2017	23	107	$16,968
2018	11	169	$17,768
2019	N/R	143	$10,779
2020	N/R	173	$7,272
2021	N/R	177	$6,607
2022	N/R	135	$4,401
2023	N/R	101	$9,537
2024	N/R	113	$5,062

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	51	51	$168
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	110	182	$138
96413	Administration of chemotherapy into vein, 1 hour or less	39	258	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	268	452	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	338	587	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	35	980	$571,516
Lenalidomide	Lenalidomide	40	1,120	$481,557
Pomalyst	Pomalidomide	17	476	$421,431
Cabometyx	Cabozantinib S-Malate	13	336	$291,591
Promacta	Eltrombopag Olamine	15	450	$196,703

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	11	$1,090
A4388	Ostomy pouch, drainable, with extended wear barrier attached, (1 piece), each	N	N/R	12	$1,081
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	14	$1,015
J8521	Capecitabine, oral, 500 mg	N	N/R	26	$858
E1392	Portable oxygen concentrator, rental	Y	N/R	11	$435

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Martha Hosford Skapof, M.D.?

Tedicare shows public-source Medicare data for Martha Hosford Skapof, M.D. (NPI 1457301657), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Martha Hosford Skapof, M.D. have ACO affiliation data?

Martha Hosford Skapof, M.D. is shown with ACO affiliation data for eBrightHealth ACO (MSSP, ACO ID A3053).

What billing organization is linked to Martha Hosford Skapof, M.D.?

Martha Hosford Skapof, M.D. is linked to CHRISTIANA CARE HEALTH SERVICES INC (billing NPI 1306375373) in the available physician profile data.

Does Martha Hosford Skapof, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.